LISA WALL: Open Payments
NPI 1205085321 · VERO BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 32 payments from 13 companies in 2025. Trend: 2023 $745 · 2024 $1,030 · 2025 $989
Food & beverage: $822Education: $167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $285 |
| E.R. Squibb & Sons, L.L.C. | 9 | $280 |
| Janssen Biotech, Inc. | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 2 | $69 |
| Galderma Laboratories, L.P. | 3 | $54 |
| UCB, Inc. | 2 | $48 |
| GENZYME CORPORATION | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: Sotyktu, SKYRIZI, TREMFYA, DUPIXENT, NEMLUVIO, BOTOX, Bimzelx, ILUMYA.
Industry payments across FL — which companies pay providers there.
